help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
Newsroom  

Advertisement


Advertisement


American 
Pharmacists 
Month

APhA CEO Blog

APhA 
Foundation



2010 International Pharmaceutical Federation PSWC and AAPS Annual 
Meeting

Print this page

FOCUS ON PULMONARY DISORDERS     Devra K. Dang, Section Advisor

Telemedicine may improve care in ICU

Key point: According to results from an observational study, implementation of a multifaceted health information technology bundle with remote intensivist coverage reduces mortality and use of mechanical ventilation in adult patients in the intensive care unit (ICU) compared with a historical control.

Finer points: An observational study was conducted in three ICUs at an academic community hospital to assess the effects of a health information technology bundle with remote intensivist coverage compared with a control group without such enhancements on outcomes such as hospital mortality, mechanical ventilator and vasopressor use, and ICU and hospital lengths of stay. The bundle consisted of interventions such as an electronic medical record with an electronic algorithmic event system, computer-assisted physician order entry, an electronic medication administration record, bar code medication administration, a radiographic picture archiving and communication system, and a two-way audio and one-way video remote monitoring system used by the telemedicine team of health providers to interact with patients and caregivers from 7:00 pm to 7:00 am. The team—an intensivist and a critical care nurse—also performed rounds every 2 hours to assess the clinical status of all monitored patients, and interventions were performed as needed.

The control group (n = 954) received care at the same institution for 16 months before implementation of the bundle, and the intervention group (n = 959) received care for 10 months after implementation. Baseline demographics were similar between the groups: mean age was 65 years, more than 86% were white, mean APACHE (Acute Physiology and Chronic Health Evaluation) acute physiology scores were approximately 57, and APACHE-predicted hospital mortality rates were approximately 19. The only significant difference between the two groups was diagnostic category—a greater percentage of patients in the control group had a cardiology diagnosis (31.0% vs. 19.8%), while a greater percentage of patients in the intervention group had a neurology diagnosis (32.3% vs. 19.1%). The investigators reported that mortality rates were significantly lower for the intervention versus control group (14.7% vs. 21.4%, P < 0.001) and that predicted mortality in the intervention group was significantly lower than that predicted by APACHE IV (29.5%, P < 0.001). In addition, ventilator use was significantly lower in the intervention versus control group (P = 0.001). No differences were seen for vasopressor use or ICU or hospital lengths of stay.

What you need to know: Not every study has shown a benefit with the use of telemedicine on outcomes in patients in the ICU. In December 2009, Eric Thomas, MD, MPH, and colleagues published results of their observational study of six ICUs in five large U.S. hospitals in JAMA. These investigators found that remote monitoring of ICU patients was not associated with an overall improvement in mortality or length of stay. A main difference between the current analysis and the Thomas study is that almost two-thirds of patients in the Thomas study had minimal exposure to tele-ICU intervention, and the teleintensivists did not have access to a computerized physician order entry system or electronic medical records in the ICUs. Additional trials are needed to fully understand the benefits of telemedicine in the ICU population.

What your patients need to know: Educate patients and their family about telemedicine and the goals of therapy if these interventions are being used.

Sources:

Posted by Alex Egervary (aegervary@aphanet.org)
June 9, 2010, 4:45 pm